Lexicon Pharmaceuticals, Inc.

LXRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$66,656$22,465$46,345$64,065
Short-Term Investments$171,301$147,561$92,012$22,678
Receivables$3,473$1,010$28$14
Inventory$231$381$0$0
Other Curr. Assets$4,532$5,130$2,481$2,164
Total Curr. Assets$246,193$176,547$140,866$88,921
Property Plant & Equip (Net)$7,316$7,511$8,478$3,445
Goodwill$44,543$44,543$44,543$44,543
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$368$828$412$0
Total NC Assets$52,227$52,882$53,433$47,988
Other Assets$0$0$0$0
Total Assets$298,420$229,429$194,299$136,909
Liabilities
Payables$14,801$14,389$10,395$9,152
Short-Term Debt$1,175$1,291$1,291$1,089
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$29,272$15,866$11,486$11,883
Total Curr. Liab.$45,248$31,546$23,172$22,124
LT Debt$107,222$104,773$54,003$1,190
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$107,222$104,773$54,003$1,190
Other Liabilities$0$0$0$0
Cap. Leases$8,099$6,556$6,715$2,279
Total Liabilities$152,470$136,319$77,175$23,314
Equity
Pref Stock$0$0$0$0
Common Stock$363$245$189$150
Retained Earnings-$1,967,242-$1,766,839-$1,589,720-$1,487,776
AOCI$119$31-$428-$10
Other Equity$2,112,710$1,859,673$1,707,083$1,601,231
Total Equity$145,950$93,110$117,124$113,595
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$298,420$229,429$194,299$136,909
Net Debt$41,741$83,599$8,949-$61,786